论文信息 - Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern - 字舞流文

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

P. Maes | E. André | J. Neyts | P. Leyssen | D. Jochmans | S. de Jonghe | Winston Chiu | L. Vangeel | J. Raymenants | Bram Slechten